Oak Longevity vs Ro: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Ro overall, scoring 7.5/10 vs 7.2/10. Oak Longevity is more affordable at $130/mo vs $149/mo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound. Choose Ro for users who want fda-approved brand-name glp-1 access includin.
A side-by-side comparison of Oak Longevity and Ro covering pricing, scores, medication types, insurance, and more to help you decide.
Oak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak LongevityRo
#36 of 42One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | Oak Longevity | Ro |
|---|---|---|
| Our Score | 7.5/10 | 7.2/10 |
| Starting Price | $130/mo | $149/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Ranking | #23 | #36 |
Pros & Cons Compared
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Ro
Pros
- +Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
- −Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
Oak Longevity edges out Ro with a score of 7.5/10 vs 7.2/10. If budget is your priority, Oak Longevity starts at $130/mo compared to Ro's $149/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin). Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.